Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial - Bleecker, E R; FitzGerald, J M; Chanez, P (Lancet, 2016)
(10056):